NIH #5R44CA285006-02
Comprehensive Assessment of Cancer Theranostics Response
- Amount
- $1.1M
- Period
- 2023-09-22 → 2026-08-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at AIQ GLOBAL INC
Prostate Cancer Treatment and Research · Pulmonary and Respiratory Medicine
7 total · 1 active
NIH #5R44CA285006-02
Awarded at AIQ GLOBAL INC
NIH #1R44CA285006-01
Awarded at AIQ GLOBAL INC
NIH #5K08CA093425-06
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17